What does positive surgical margins mean for HER2-Positive Breast Cancer

Understanding Positive Surgical Margins in HER2-Positive Breast Cancer

I appreciate this important question. Let me explain what positive margins mean and how they're specifically relevant to your HER2-positive diagnosis.

What "Positive Margins" Means

When surgeons remove a breast cancer tumor, they also remove some surrounding healthy tissue as a safety buffer. The edges of this removed tissue are called "margins."

Positive margins means that cancer cells were found at the very edge of the tissue that was removed—essentially, the surgeon didn't get a complete buffer zone of healthy tissue around the tumor. This suggests some cancer cells may have been left behind in your breast.

Why This Matters for HER2-Positive Breast Cancer

For HER2-positive breast cancer specifically, positive margins are particularly important because:

1. HER2-positive cancers tend to be more aggressive - They grow faster than some other breast cancer types, which means any remaining cells have greater potential to grow back

2. You have effective targeted therapies available - The good news is that HER2-positive breast cancers respond well to anti-HER2 treatments like trastuzumab (Herceptin) and newer drugs like trastuzumab deruxtecan (Enhertu). According to research on proteomics and HER2 expression, patients with high HER2 levels who receive anti-HER2 therapy show excellent long-term outcomes—some studies show patients with very high HER2 expression had "no events at all" when followed for 6-7 years with anti-HER2 treatment.

What Typically Happens Next

Positive margins usually lead to:

• Re-excision surgery (removing more tissue to achieve clear margins), OR
• Radiation therapy to the breast to eliminate any remaining microscopic disease
• Continued systemic therapy (chemotherapy + anti-HER2 targeted therapy) to address any cancer cells that may have spread beyond the surgical area

Questions to Ask Your Oncology Team

Since positive margins require careful management, here are specific questions to discuss:

1. How extensive are the positive margins? (Are they at one edge or multiple edges? How many millimeters of cancer cells were present?)

2. What is your recommendation—re-excision surgery, radiation, or both? (Understanding the reasoning helps you make informed decisions)

3. How will positive margins affect my HER2-positive breast cancer treatment plan? (Will it change the duration or intensity of anti-HER2 therapy?)

4. What is the recurrence risk with my specific margin status, and how does anti-HER2 therapy reduce that risk? (This helps you understand the benefit of the targeted treatments available to you)

5. Should I have any additional imaging or testing before deciding on next steps? (Such as MRI to assess the full extent of disease)

The Encouraging Part

The fact that you have HER2-positive breast cancer is actually advantageous when dealing with positive margins. According to NCCN Guidelines for HER2-positive breast cancer, patients with this subtype benefit significantly from anti-HER2 targeted therapies. The combination of surgery (with or without re-excision), radiation if needed, and anti-HER2 systemic therapy provides multiple layers of treatment to address any remaining disease.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.